Philogen
A clinical-stage biotech developing targeted biopharmaceuticals for cancer treatment.
PHIL | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005373789 (+1 more)
- LEI:
- 81560009EA1577917768
- Country:
- Italy
- Address:
- PIAZZA LA LIZZA, 7, 53100 SIENA
- Website:
- https://www.philogen.com
- Sector:
- Manufacturing
Description
Philogen is a clinical-stage biotechnology company focused on the discovery and development of novel biopharmaceutical products for the treatment of cancer and other serious conditions associated with angiogenesis. Founded in 1996, the company's core strategy is based on innovating targeted therapies, such as antibody-cytokine fusions, which are designed to selectively deliver therapeutic agents to the site of disease. This approach aims to increase efficacy while reducing toxicity. Philogen operates as an integrated company with capabilities in research, GMP manufacturing, and clinical development of its proprietary product pipeline.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-09 13:30 |
2025 12 09 - CS Settimanale acquisto azioni proprie
|
Italian | 294.9 KB | ||
| 2025-11-11 20:02 |
The Board of Directors approves the financial position for the third quarter of…
|
Italian | 292.6 KB | ||
| 2025-11-11 20:01 |
Il Consiglio di Amministrazione approva la Posizione Finanziaria Netta relativa…
|
Italian | 295.3 KB | ||
| 2025-11-10 12:39 |
Allegato 3F
|
Italian | 26.5 KB | ||
| 2025-10-13 13:36 |
2025 10 13 - CS settimanale acquisto azioni proprie
|
Italian | 295.3 KB | ||
| 2025-10-06 18:50 |
Allegato 3F
|
Italian | 26.9 KB | ||
| 2025-10-06 18:15 |
2025 10 06 - CS settimanale acquisto azioni proprie
|
Italian | 294.0 KB | ||
| 2025-09-29 17:58 |
2025 09 29 - CS settimanale acquisto azioni proprie
|
Italian | 298.0 KB | ||
| 2025-09-26 12:26 |
Half Year Report 2025 as of 30.06.2025 (Courtesy English Translation)
|
English | 2.1 MB | ||
| 2025-09-26 12:24 |
Relazione Finanziaria Semestrale al 30.06.2025
|
Italian | 2.0 MB | ||
| 2025-09-23 21:11 |
The Board of Directors Approves the Half-Yearly Financial Report at 30 June 202…
|
English | 416.6 KB | ||
| 2025-09-23 21:10 |
Il Consiglio di Amministrazione Approva la Relazione Finanziaria Semestrale al …
|
Italian | 377.0 KB | ||
| 2025-09-15 14:52 |
2025 09 15 - CS settimanale acquisto azioni proprie
|
Italian | 184.3 KB | ||
| 2025-08-18 20:02 |
Press Release Clearance e Closing OncoACP3 (Price Sensitive)
|
Italian | 213.9 KB | ||
| 2025-07-07 16:50 |
2025 07 07 - CS settimanale acquisto azioni proprie
|
Italian | 153.0 KB |
Automate Your Workflow. Get a real-time feed of all Philogen filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Philogen
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Philogen via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
